{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:31:41Z","timestamp":1793424701721,"version":"4.5.0"},"reference-count":310,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Lupus nephritis (LN), a severe complication of systemic lupus erythematosus (SLE), is associated with increased morbidity and mortality. The pathogenesis of LN involves complex immune-mediated mechanisms that alter the biology of renal resident epithelial cells. Emerging evidence highlights the bidirectional interactions between immune cells and renal epithelial cells\u2014including podocytes and tubular epithelial cells(TECs)\u2014as critical contributors to disease progression. These interactions shape local immune responses, drive inflammatory injury, and disrupt renal function. However, the molecular and cellular basis of this crosstalk remains incompletely understood. Recent advances have uncovered key mechanisms underlying these interactions and identified potential therapeutic targets that may inform future treatment strategies. This review summarizes current findings on the immunological roles of renal epithelial cells in LN and discusses their relevance to the development of targeted and cell-specific therapeutic interventions.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1682075","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T05:11:50Z","timestamp":1764047510000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Podocyte, tubular epithelial-immune cell interplay in the pathogenesis of lupus nephritis"],"prefix":"10.3389","volume":"16","author":[{"given":"Jingyi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Rui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"Itc81","DOI":"10.7326\/AITC202006020","article-title":"Systemic lupus erythematosus","volume":"172","author":"Kiriakidou","year":"2020","journal-title":"Ann Intern Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2009.12.008","article-title":"The geoepidemiology of systemic lupus erythematosus","volume":"9","author":"Borchers","year":"2010","journal-title":"Autoimmun Rev"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000480","article-title":"Epidemiology of systemic lupus erythematosus: an update","volume":"30","author":"Stojan","year":"2018","journal-title":"Curr Opin Rheumatol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3892\/mmr.2023.13091","article-title":"Immune podocytes in the immune microenvironment of lupus nephritis (Review)","volume":"28","author":"Liu","year":"2023","journal-title":"Mol Med Rep"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.686501","article-title":"Gut microbiome and metabolites in systemic lupus erythematosus: link, mechanisms and intervention","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/art.23626","article-title":"Glomerular targets of nephritogenic autoantibodies in systemic lupus erythematosus","volume":"58","author":"Van Bavel","year":"2008","journal-title":"Arthritis Rheum"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000089","article-title":"The pathogenesis, diagnosis and treatment\u00a0of\u00a0lupus nephritis","volume":"26","author":"Schwartz","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2015.159","article-title":"What is damaging the kidney in lupus nephritis","volume":"12","author":"Davidson","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev311","article-title":"The frequency and outcome of lupus nephritis: results from an international inception cohort study","volume":"55","author":"Hanly","year":"2016","journal-title":"Rheumatol (Oxford)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00103","article-title":"Early life factors associated with adult-onset systemic lupus erythematosus in women","volume":"7","author":"Parks","year":"2016","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2016.03.042","article-title":"Insights into the epidemiology and management of lupus nephritis from the US rheumatologist\u2019s perspective","volume":"90","author":"Hoover","year":"2016","journal-title":"Kidney Int"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2011.04.032","article-title":"Epidemiology and management of refractory lupus nephritis","volume":"10","author":"Pons-Estel","year":"2011","journal-title":"Autoimmun Rev"},{"key":"B13","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/01.md.0000091181.93122.55","article-title":"Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients","volume":"82","author":"Cervera","year":"2003","journal-title":"Med (Baltimore)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"102871","DOI":"10.1016\/j.jaut.2022.102871","article-title":"Lupus nephritis: new progress in diagnosis and treatment","volume":"132","author":"Yu","year":"2022","journal-title":"J Autoimmun"},{"key":"B15","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1053\/j.ackd.2006.10.001","article-title":"The prevalence of symptoms in end-stage renal disease: a systematic review","volume":"14","author":"Murtagh","year":"2007","journal-title":"Adv Chronic Kidney Dis"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2009.08.008","article-title":"Impact of pain and symptom burden on the health-related quality of life of hemodialysis patients","volume":"39","author":"Davison","year":"2010","journal-title":"J Pain Symptom Manage"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/S0020-7489(01)00030-X","article-title":"Self-care self-efficacy, depression, and quality of life among patients receiving hemodialysis in Taiwan","volume":"39","author":"Tsay","year":"2002","journal-title":"Int J Nurs Stud"},{"key":"B18","doi-asserted-by":"publisher","first-page":"151549","DOI":"10.1016\/j.apnr.2021.151549","article-title":"Symptom management in Chinese adults with end stage renal disease (ESRD)","volume":"64","author":"Levy","year":"2022","journal-title":"Appl Nurs Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"A7","DOI":"10.1053\/j.ajkd.2017.01.036","article-title":"US\u00a0renal data system 2016 annual data report: epidemiology of kidney disease\u00a0in the United States","volume":"69","author":"Saran","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(02)01118-X","article-title":"Demographic differences in\u00a0the development of lupus nephritis: a retrospective analysis","volume":"112","author":"Seligman","year":"2002","journal-title":"Am J Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1191\/0961203302lu158oa","article-title":"Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis","volume":"11","author":"Bastian","year":"2002","journal-title":"Lupus"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/art.37795","article-title":"Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000\u20132004","volume":"65","author":"Feldman","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20683","article-title":"Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortality","volume":"64","author":"Jakes","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23887","article-title":"Racial and ethnic differences in the prevalence and time to onset of manifestations of systemic lupus erythematosus: the california lupus surveillance project","volume":"72","author":"Maningding","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41572-019-0141-9","article-title":"Lupus nephritis","volume":"6","author":"Anders","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1191\/0961203305lu2245oa","article-title":"Male systemic lupus erythematosus in a Latin-American inception cohort of 1214 patients","volume":"14","author":"Garcia","year":"2005","journal-title":"Lupus"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1191\/096120398678920479","article-title":"The clinical features and prognosis of male lupus in Taiwan","volume":"7","author":"Chang","year":"1998","journal-title":"Lupus"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1191\/096120399678847605","article-title":"Clinical characteristics and outcome of southern Chinese males with systemic lupus erythematosus","volume":"8","author":"Mok","year":"1999","journal-title":"Lupus"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/art.22375","article-title":"Accelerated damage accrual among men with systemic lupus erythematosus: XLIV. Results from a multiethnic US cohort","volume":"56","author":"Andrade","year":"2007","journal-title":"Arthritis Rheum"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1177\/0961203311403640","article-title":"Clinical expression and morbidity of systemic lupus erythematosus during a post-diagnostic 5-year follow-up: a male:female comparison","volume":"20","author":"Stefanidou","year":"2011","journal-title":"Lupus"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1191\/096120399678847786","article-title":"Immunological and clinical differences between juvenile and adult onset of systemic lupus erythematosus","volume":"8","author":"Carre\u00f1o","year":"1999","journal-title":"Lupus"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2004.12.045","article-title":"Initial presentation of childhood-onset systemic lupus erythematosus: a French multicenter study","volume":"146","author":"Bader-Meunier","year":"2005","journal-title":"J Pediatr"},{"key":"B33","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1177\/0961203307088006","article-title":"Childhood systemic lupus erythematosus in Latin America. The GLADEL experience in 230 children","volume":"17","author":"Ram\u00edrez G\u00f3mez","year":"2008","journal-title":"Lupus"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.094813","article-title":"Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus","volume":"68","author":"Hoffman","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2019.1580512","article-title":"Podocytes and autophagy: a potential therapeutic target in lupus nephritis","volume":"15","author":"Zhou","year":"2019","journal-title":"Autophagy"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02113","article-title":"Calcium\/calmodulin kinase IV controls the function of both T cells and kidney resident cells","volume":"9","author":"Ferretti","year":"2018","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.189688","article-title":"Activation of Nod-like receptor protein 3 inflammasomes turns on podocyte injury and glomerular sclerosis in hyperhomocysteinemia","volume":"60","author":"Zhang","year":"2012","journal-title":"Hypertension"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004110917","article-title":"Effect of human anti-DNA antibodies on proximal renal tubular epithelial cell cytokine expression: implications on tubulointerstitial inflammation in lupus nephritis","volume":"16","author":"Yung","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"108445","DOI":"10.1016\/j.clim.2020.108445","article-title":"Update on the cellular and molecular aspects of lupus nephritis","volume":"216","author":"Frangou","year":"2020","journal-title":"Clin Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.34067\/KID.0000000000000531","article-title":"Lupus nephritis: immune cells and the kidney microenvironment","volume":"5","author":"Chernova","year":"2024","journal-title":"Kidney360"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2013.11.023","article-title":"Lupus nephritis: the evolving role of novel therapeutics","volume":"63","author":"Rovin","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"B42","doi-asserted-by":"publisher","first-page":"110180","DOI":"10.1016\/j.clim.2024.110180","article-title":"The role of podocytes in lupus nephritis: Insights and implications","volume":"262","author":"Ichinose","year":"2024","journal-title":"Clin Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8091340","article-title":"Podocyte injury in lupus nephritis","volume":"8","author":"Sakhi","year":"2019","journal-title":"J Clin Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2016.01.012","article-title":"Podocyte injury and its consequences","volume":"89","author":"Nagata","year":"2016","journal-title":"Kidney Int"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1106556","article-title":"Focal segmental glomerulosclerosis","volume":"365","author":"D\u2019Agati","year":"2011","journal-title":"N Engl J Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/art.43200","article-title":"Aberrant glycosylation of igG in children with active lupus nephritis alters podocyte metabolism and causes podocyte injury","volume":"77","author":"Bhargava","year":"2025","journal-title":"Arthritis Rheumatol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000481633","article-title":"A review of podocyte biology","volume":"47","author":"Garg","year":"2018","journal-title":"Am J Nephrol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2013.169","article-title":"The podocyte slit diaphragm\u2013from a thin grey line to a complex signalling hub","volume":"9","author":"Grahammer","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00948-07","article-title":"Neph1 cooperates with nephrin to transduce a signal that induces actin polymerization","volume":"27","author":"Garg","year":"2007","journal-title":"Mol Cell Biol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"105852","DOI":"10.1016\/j.phrs.2021.105852","article-title":"Deciphering nutritional interventions for podocyte structure and function","volume":"172","author":"Afsar","year":"2021","journal-title":"Pharmacol Res"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfad289","article-title":"Early growth response 1 as a podocyte injury marker in human glomerular diseases","volume":"17","author":"Okabe","year":"2024","journal-title":"Clin Kidney J"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-biophys-042910-155359","article-title":"Actin structure and function","volume":"40","author":"Dominguez","year":"2011","journal-title":"Annu Rev Biophys"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.12.028","article-title":"Actin dynamics at focal adhesions: a common endpoint and\u00a0putative therapeutic target for proteinuric kidney diseases","volume":"93","author":"Sever","year":"2018","journal-title":"Kidney Int"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200523371","article-title":"Synaptopodin regulates the actin-bundling activity of alpha-actinin in an isoform-specific manner","volume":"115","author":"Asanuma","year":"2005","journal-title":"J\u00a0Clin Invest"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/ncb1400","article-title":"Synaptopodin orchestrates actin organization and cell motility via regulation of RhoA signalling","volume":"8","author":"Asanuma","year":"2006","journal-title":"Nat Cell Biol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.876054","article-title":"Umbilical cord mesenchymal stem cells ameliorate kidney injury in MRL\/ipr mice through the TGF-\u03b21 pathway","volume":"10","author":"Huang","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000578","article-title":"The immune podocyte","volume":"31","author":"Bhargava","year":"2019","journal-title":"Curr Opin Rheumatol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1002\/art.20103","article-title":"Is alpha-actinin a target for pathogenic anti-DNA antibodies in lupus nephritis","volume":"50","author":"Mason","year":"2004","journal-title":"Arthritis Rheum"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014050493","article-title":"Glomerular autoimmune multicomponents of human lupus nephritis in vivo (2): planted antigens","volume":"26","author":"Bruschi","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/nri2155","article-title":"FcRn: the neonatal Fc receptor comes of age","volume":"7","author":"Roopenian","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013050498","article-title":"Neonatal Fc receptor promotes immune complex-mediated glomerular disease","volume":"25","author":"Olaru","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1002\/art.39499","article-title":"Lupus nephritis igG induction of calcium\/calmodulin-dependent protein kinase IV expression in podocytes and alteration of their function","volume":"68","author":"Ichinose","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2012020133","article-title":"Podocytes are nonhematopoietic professional antigen-presenting cells","volume":"24","author":"Goldwich","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s11926-024-01175-4","article-title":"The role of podocytes in lupus pathology","volume":"27","author":"Maeda","year":"2024","journal-title":"Curr Rheumatol Rep"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0000000000000124","article-title":"Podocyte injury and repair mechanisms","volume":"24","author":"Cellesi","year":"2015","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20210562","article-title":"Monocytes transition to macrophages within the inflamed vasculature via monocyte CCR2 and endothelial TNFR2","volume":"219","author":"Mysore","year":"2022","journal-title":"J Exp Med"},{"key":"B67","doi-asserted-by":"publisher","first-page":"13074","DOI":"10.1038\/s41598-023-40346-8","article-title":"Mesenchymal stem cells enhance CCL8 expression by podocytes in lupus-prone MRL.Fas(lpr) mice","volume":"13","author":"Kim","year":"2023","journal-title":"Sci Rep"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1084\/jem.193.12.1393","article-title":"Aberrant high expression of B lymphocyte chemokine (BLC\/CXCL13) by C11b+CD11c+ dendritic cells in murine lupus and preferential chemotaxis of B1 cells towards BLC","volume":"193","author":"Ishikawa","year":"2001","journal-title":"J Exp Med"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12380","article-title":"Pathogenetic role of glomerular CXCL13 expression in lupus nephritis","volume":"178","author":"Worthmann","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005040426","article-title":"Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL\/lpr lupus-prone mice","volume":"16","author":"P\u00e9rez de Lema","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1084\/jem.190.12.1813","article-title":"Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) mice","volume":"190","author":"Tesch","year":"1999","journal-title":"J Exp Med"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2006.12.051","article-title":"Transcriptional suppression of nephrin in podocytes by macrophages: roles of inflammatory cytokines and involvement of the PI3K\/Akt pathway","volume":"581","author":"Takano","year":"2007","journal-title":"FEBS Lett"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2009.12.002","article-title":"Definition of human autoimmunity\u2013autoantibodies versus autoimmune disease","volume":"9","author":"Lleo","year":"2010","journal-title":"Autoimmun Rev"},{"key":"B74","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12929-018-0436-2","article-title":"Toll-like receptors in lupus nephritis","volume":"25","author":"Devarapu","year":"2018","journal-title":"J BioMed Sci"},{"key":"B75","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/BOR.0000000000000577","article-title":"Neutrophils in lupus nephritis","volume":"31","author":"Nishi","year":"2019","journal-title":"Curr Opin Rheumatol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.11.018","article-title":"Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment","volume":"159","author":"Lavin","year":"2014","journal-title":"Cell"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01462","article-title":"The metabolic signature of macrophage responses","volume":"10","author":"Viola","year":"2019","journal-title":"Front Immunol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12910","article-title":"Implications of macrophage polarization in autoimmunity","volume":"154","author":"Funes","year":"2018","journal-title":"Immunology"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0208132","article-title":"Identification of alterations in macrophage activation associated with disease activity in systemic lupus erythematosus","volume":"13","author":"Labonte","year":"2018","journal-title":"PloS One"},{"key":"B80","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/ndt\/gfy195","article-title":"Mesenchymal stem cells prevent podocyte injury in lupus-prone B6.MRL-Faslpr mice via polarizing macrophage into an anti-inflammatory phenotype","volume":"34","author":"Zhang","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0398-x","article-title":"The immune cell landscape in kidneys of patients with lupus nephritis","volume":"20","author":"Arazi","year":"2019","journal-title":"Nat Immunol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jaut.2019.01.004","article-title":"PAM3 supports the generation of M2-like macrophages from lupus patient monocytes and improves disease outcome in murine lupus","volume":"99","author":"Horuluoglu","year":"2019","journal-title":"J Autoimmun"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1335936","article-title":"Understanding the podocyte immune responses in proteinuric kidney diseases: from pathogenesis to therapy","volume":"14","author":"Jiang","year":"2023","journal-title":"Front Immunol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2008.04.013","article-title":"Human neutrophil Fcgamma\u00a0receptors initiate and play specialized nonredundant roles in antibody-mediated inflammatory diseases","volume":"28","author":"Tsuboi","year":"2008","journal-title":"Immunity"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2010.11.025","article-title":"Dendritic cells in lupus are not required for activation of T and B cells but promote their expansion, resulting in tissue damage","volume":"33","author":"Teichmann","year":"2010","journal-title":"Immunity"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2016.10.005","article-title":"Unraveling the podocyte injury in lupus nephritis: Clinical and experimental approaches","volume":"46","author":"Dos","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"B87","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.molmed.2009.12.005","article-title":"Pathogenesis of human systemic lupus erythematosus: recent advances","volume":"16","author":"Crisp\u00edn","year":"2010","journal-title":"Trends Mol Med"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2007.02.001","article-title":"Anti-alpha-actinin antibodies: a new marker of lupus nephritis","volume":"6","author":"Renaudineau","year":"2007","journal-title":"Autoimmun Rev"},{"key":"B89","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.cyto.2014.09.011","article-title":"T cell subsets and their\u00a0signature cytokines in autoimmune and inflammatory diseases","volume":"74","author":"Raphael","year":"2015","journal-title":"Cytokine"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00093.2019","article-title":"Human Th17 cells produce a soluble mediator that increases podocyte motility via signaling pathways that mimic PAR-1 activation","volume":"317","author":"May","year":"2019","journal-title":"Am J Physiol Renal Physiol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12645","article-title":"Interleukin-17A participates in podocyte injury by inducing IL-1\u03b2 secretion through ROS-NLRP3 inflammasome-caspase-1 pathway","volume":"87","author":"Yan","year":"2018","journal-title":"Scand J Immunol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.654912","article-title":"The th17\/IL-17 axis and kidney diseases, with focus on lupus nephritis","volume":"8","author":"Paquissi","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B93","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/1756-185X.13743","article-title":"\u03b1-mangostin attenuates pristane-induced lupus nephritis by regulating Th17 differentiation","volume":"23","author":"Zhou","year":"2020","journal-title":"Int J Rheum Dis"},{"key":"B94","doi-asserted-by":"publisher","first-page":"2431617","DOI":"10.1155\/2019\/2431617","article-title":"3\u03b2-acetyloxy-oleanolic acid attenuates pristane-induced lupus nephritis by regulating th17 differentiation","volume":"2019","author":"Zhou","year":"2019","journal-title":"J Immunol Res"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1002\/art.40155","article-title":"Podocyte activation of NLRP3 inflammasomes contributes to the development of proteinuria in lupus nephritis","volume":"69","author":"Fu","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1111\/nep.12785","article-title":"The NLRP3 inflammasome in kidney disease and autoimmunity","volume":"21","author":"Hutton","year":"2016","journal-title":"Nephrol (Carlton)"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1159\/000058401","article-title":"Predominance of type-2 immune response in idiopathic membranous nephropathy. Cytoplasmic cytokine analysis","volume":"91","author":"Hirayama","year":"2002","journal-title":"Nephron"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2004.03.029","article-title":"Evaluation of T helper-1\/-2 balance on the basis of IgG subclasses and serum cytokines in children with glomerulonephritis","volume":"44","author":"Kawasaki","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfg572","article-title":"Up-regulated interleukin-4 production by peripheral T-helper cells in idiopathic membranous nephropathy","volume":"19","author":"Masutani","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac037","article-title":"Renal mTORC1 activation is associated with disease activity and prognosis in lupus nephritis","volume":"61","author":"Mao","year":"2022","journal-title":"Rheumatol (Oxford)"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2023-000896","article-title":"Glomerular mTORC1 activation was associated with podocytes to endothelial cells communication in lupus nephritis","volume":"10","author":"Liu","year":"2023","journal-title":"Lupus Sci Med"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.04.007","article-title":"Mechanisms and functions of inflammasomes","volume":"157","author":"Lamkanfi","year":"2014","journal-title":"Cell"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.134.2.852","article-title":"Treatment of murine lupus with monoclonal anti-T cell antibody","volume":"134","author":"Wofsy","year":"1985","journal-title":"J Immunol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.1.489","article-title":"Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB\/W F1 mice by a mechanism downstream of renal immune complex deposition","volume":"171","author":"Schiffer","year":"2003","journal-title":"J Immunol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1002\/path.5508","article-title":"Podocytes present antigen to activate specific T cell immune responses in inflammatory renal disease","volume":"252","author":"Li","year":"2020","journal-title":"J Pathol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1172\/JCI122045","article-title":"CD8+ cells and glomerular crescent formation: outside-in as well as inside-out","volume":"128","author":"Kitching","year":"2018","journal-title":"J Clin Invest"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0b013e32834583ec","article-title":"New insights into the pathogenesis of cellular crescents","volume":"20","author":"Singh","year":"2011","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfs543","article-title":"Toll-like receptor 3 ligand, polyIC, induces proteinuria and glomerular CD80, and increases urinary CD80 in mice","volume":"28","author":"Ishimoto","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1172\/JCI20402","article-title":"Induction of B7\u20131 in podocytes is associated with nephrotic syndrome","volume":"113","author":"Reiser","year":"2004","journal-title":"J Clin Invest"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2013.276","article-title":"Proteinuria: abate or applaud abatacept in proteinuric kidney disease","volume":"10","author":"Reiser","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1038\/70905","article-title":"T-cell stimulation: an abundance of B7s","volume":"5","author":"Abbas","year":"1999","journal-title":"Nat Med"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5699(98)01418-2","article-title":"Structure and evolution of the extended B7 family","volume":"20","author":"Henry","year":"1999","journal-title":"Immunol Today"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1002\/art.30085","article-title":"Suppression of autoimmunity and organ pathology in lupus-prone mice upon inhibition of calcium\/calmodulin-dependent protein kinase type IV","volume":"63","author":"Ichinose","year":"2011","journal-title":"Arthritis Rheum"},{"key":"B114","doi-asserted-by":"publisher","first-page":"114249","DOI":"10.1016\/j.celrep.2024.114249","article-title":"Podocyte SIRP\u03b1 reduction aggravates lupus nephritis via promoting T cell inflammatory responses","volume":"43","author":"Qian","year":"2024","journal-title":"Cell Rep"},{"key":"B115","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.coi.2020.10.014","article-title":"Type I interferon in the pathogenesis of systemic lupus erythematosus","volume":"67","author":"Postal","year":"2020","journal-title":"Curr Opin Immunol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013010026","article-title":"The pathogenesis of lupus nephritis","volume":"24","author":"Lech","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2016.04.010","article-title":"T cells and IL-17 in lupus nephritis","volume":"185","author":"Koga","year":"2017","journal-title":"Clin Immunol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1177\/0961203310389100","article-title":"IL-17-producing T cells in lupus nephritis","volume":"20","author":"Apostolidis","year":"2011","journal-title":"Lupus"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2019.1593141","article-title":"The role of IL-17 in systemic lupus erythematosus and its potential as a therapeutic target","volume":"15","author":"Koga","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.624971","article-title":"Current insights and future prospects for targeting IL-17 to treat patients with systemic lupus erythematosus","volume":"11","author":"Koga","year":"2020","journal-title":"Front Immunol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12723","article-title":"DC-SIGN expression on podocytes and its role in inflammatory immune response of lupus nephritis","volume":"183","author":"Cai","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202784","article-title":"Urinary CD4 T cells identify SLE patients with proliferative lupus nephritis and can be used to monitor treatment response","volume":"73","author":"Enghard","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-0401-9","article-title":"Protecting the kidney in systemic lupus erythematosus: from diagnosis to therapy","volume":"16","author":"Maria","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1159\/000368581","article-title":"Lupus nephritis: from pathogenesis to targets for biologic treatment","volume":"128","author":"Liu","year":"2014","journal-title":"Nephron Clin Pract"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30237-5","article-title":"Management strategies and future directions for systemic lupus erythematosus in adults","volume":"393","author":"Durcan","year":"2019","journal-title":"Lancet"},{"key":"B126","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2018.11.001","article-title":"Systemic lupus erythematosus: Diagnosis and clinical management","volume":"96","author":"Fava","year":"2019","journal-title":"J Autoimmun"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241210066","article-title":"Decipher the immunopathological mechanisms and set up potential therapeutic strategies for patients with lupus nephritis","volume":"24","author":"Tsai","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007060686","article-title":"Complement-mediated dysfunction of glomerular filtration barrier accelerates progressive renal injury","volume":"19","author":"Abbate","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2006.051329","article-title":"Nephritogenic lupus antibodies recognize glomerular basement membrane-associated chromatin fragments released from apoptotic intraglomerular cells","volume":"168","author":"Kalaaji","year":"2006","journal-title":"Am J Pathol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V114632","article-title":"Characterization and localization of the neonatal Fc receptor in adult human kidney","volume":"11","author":"Haymann","year":"2000","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1172\/JCI99507","article-title":"CaMK4 compromises podocyte function in autoimmune and nonautoimmune kidney disease","volume":"128","author":"Maeda","year":"2018","journal-title":"J Clin Invest"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16140","article-title":"N-glycosylated IgG in patients with kidney transplants increases calcium\/calmodulin kinase IV in podocytes and causes injury","volume":"21","author":"Bhargava","year":"2021","journal-title":"Am J Transplant"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.081828","article-title":"Cross-species binding analyses of mouse and human neonatal Fc receptor show dramatic differences in immunoglobulin G and albumin binding","volume":"285","author":"Andersen","year":"2010","journal-title":"J Biol Chem"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213028","article-title":"Increased autophagy is cytoprotective against podocyte injury induced by antibody and interferon-\u03b1 in lupus nephritis","volume":"77","author":"Qi","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus","volume":"365","author":"Tsokos","year":"2011","journal-title":"N Engl J Med"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.147789","article-title":"Aberrantly glycosylated IgG elicits pathogenic signaling in podocytes and signifies lupus nephritis","volume":"6","author":"Bhargava","year":"2021","journal-title":"JCI Insight"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1001983","article-title":"In situ B cell-mediated immune responses and tubulointerstitial inflammation in human lupus nephritis","volume":"186","author":"Chang","year":"2011","journal-title":"J Immunol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2017.34","article-title":"T cells and autoimmune kidney disease","volume":"13","author":"Su\u00e1rez-Fueyo","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2017.107","article-title":"Mitochondrial energetics in the kidney","volume":"13","author":"Bhargava","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"B140","doi-asserted-by":"publisher","first-page":"9353","DOI":"10.1038\/s41598-018-27107-8","article-title":"Tubular iron deposition and iron handling proteins in human healthy kidney and chronic kidney disease","volume":"8","author":"Van Raaij","year":"2018","journal-title":"Sci Rep"},{"key":"B141","article-title":"Monocyte chemoattractant protein-1 expression in renal tissue is associated with monocyte recruitment and tubulo-interstitial lesions in patients with lupus nephritis","volume":"114","author":"Dai","year":"2001","journal-title":"Chin Med J (Engl)"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1994.144","article-title":"Extracellular matrix accumulation in immune-mediated tubulointerstitial injury","volume":"45","author":"Tang","year":"1994","journal-title":"Kidney Int"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.1984.tb02324.x","article-title":"Tubulo-interstitial disease in lupus nephritis. A morphometric study","volume":"8","author":"Magil","year":"1984","journal-title":"Histopathology"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.578952","article-title":"The emerging role of renal tubular epithelial cells in the immunological pathophysiology of lupus nephritis","volume":"11","author":"Hong","year":"2020","journal-title":"Front Immunol"},{"key":"B145","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/s41419-018-1157-x","article-title":"Renal tubular epithelial cells: the neglected mediator of tubulointerstitial fibrosis after injury","volume":"9","author":"Qi","year":"2018","journal-title":"Cell Death Dis"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.09.033","article-title":"Renal tubule injury: a driving force toward chronic kidney disease","volume":"93","author":"Liu","year":"2018","journal-title":"Kidney Int"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-016-8533-z","article-title":"Molecular and immunological basis of tubulo-interstitial injury in lupus nephritis: a comprehensive review","volume":"52","author":"Yung","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"B148","article-title":"Monocyte chemoattractant protein-1 is excreted in excessive amounts in the urine of patients with lupus nephritis","volume":"73","author":"Noris","year":"1995","journal-title":"Lab Invest"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1361.084","article-title":"The interplay of chemokines and dendritic cells in the pathogenesis of lupus nephritis","volume":"1051","author":"Tucci","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1126\/science.271.5248.509","article-title":"Receptor-ligand interaction between CD44 and osteopontin (Eta-1)","volume":"271","author":"Weber","year":"1996","journal-title":"Science"},{"key":"B151","doi-asserted-by":"publisher","first-page":"103211","DOI":"10.1016\/j.autrev.2022.103211","article-title":"Macrophages in Lupus Nephritis: Exploring a potential new therapeutic avenue","volume":"21","author":"Kwant","year":"2022","journal-title":"Autoimmun Rev"},{"key":"B152","article-title":"Tubulointerstitial disease in glomerulonephritis. Potential role of osteopontin (uropontin)","volume":"144","author":"Pichler","year":"1994","journal-title":"Am J Pathol"},{"key":"B153","first-page":"50","article-title":"A functional role for osteopontin in experimental crescentic glomerulonephritis in the rat","volume":"110","author":"Yu","year":"1998","journal-title":"Proc Assoc Am Physicians"},{"key":"B154","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1053\/ajkd.2000.9790","article-title":"Tubular osteopontin expression in human glomerulonephritis and renal vasculitis","volume":"36","author":"Okada","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.3109\/08916939808996282","article-title":"Enhanced osteopontin expression and macrophage infiltration in MRL-Fas(lpr) mice with lupus nephritis","volume":"28","author":"W\u00fcthrich","year":"1998","journal-title":"Autoimmunity"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2011.32","article-title":"The possible role of ChemR23\/Chemerin axis in the recruitment of dendritic cells in lupus nephritis","volume":"79","author":"De Palma","year":"2011","journal-title":"Kidney Int"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2005.00997.x","article-title":"MIP-3alpha\/CCL20 in renal transplantation and its possible involvement as\u00a0dendritic cell chemoattractant in allograft rejection","volume":"5","author":"Woltman","year":"2005","journal-title":"Am J Transplant"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224788","article-title":"Single-cell profiling reveals kidney CD163(+) dendritic cell participation in human lupus nephritis","volume":"83","author":"Chen","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.584414","article-title":"Interleukin-22 from type 3 innate lymphoid cells aggravates lupus nephritis by promoting macrophage infiltration in lupus-prone mice","volume":"12","author":"Hu","year":"2021","journal-title":"Front Immunol"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2018090901","article-title":"IL-34-dependent intrarenal and systemic mechanisms promote lupus nephritis in MRL-fas(lpr) mice","volume":"30","author":"Wada","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"B161","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41419-022-05018-x","article-title":"LncRNA IRAR regulates chemokines production in tubular epithelial cells thus promoting kidney ischemia-reperfusion injury","volume":"13","author":"Jia","year":"2022","journal-title":"Cell Death Dis"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00037.2022","article-title":"Chemokine CCL2 from proximal tubular epithelial cells contributes to sepsis-induced acute kidney injury","volume":"323","author":"Jia","year":"2022","journal-title":"Am J Physiol Renal Physiol"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.407","article-title":"Fractalkine-CX3CR1-dependent recruitment and retention of human CD1c+ myeloid dendritic\u00a0cells by in vitro-activated proximal tubular epithelial cells","volume":"87","author":"Kassianos","year":"2015","journal-title":"Kidney Int"},{"key":"B164","doi-asserted-by":"publisher","first-page":"102668","DOI":"10.1016\/j.autrev.2020.102668","article-title":"Phoenix from the flames: Rediscovering the role of the CD40-CD40L pathway in systemic lupus erythematosus and lupus nephritis","volume":"19","author":"Ramanujam","year":"2020","journal-title":"Autoimmun Rev"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa053","article-title":"Immunological characteristics and possible pathogenic role of urinary CD11c+ macrophages in lupus nephritis","volume":"59","author":"Kim","year":"2020","journal-title":"Rheumatol (Oxford)"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.6.4055","article-title":"Distinct in vivo roles of colony-stimulating factor-1 isoforms in renal inflammation","volume":"177","author":"Jang","year":"2006","journal-title":"J Immunol"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2009050499","article-title":"Circulating CSF-1 promotes monocyte and macrophage phenotypes that enhance lupus nephritis","volume":"20","author":"Menke","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2017050523","article-title":"Exosomal CCL2 from tubular epithelial cells is critical for albumin-induced tubulointerstitial inflammation","volume":"29","author":"Lv","year":"2018","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-019-0349-y","article-title":"Exosomal miRNA-19b-3p of tubular epithelial cells promotes M1 macrophage activation in kidney injury","volume":"27","author":"Lv","year":"2020","journal-title":"Cell Death Differ"},{"key":"B170","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3892\/ijmm.2022.5172","article-title":"Macrophage\u2212derived exosomal miRNA\u2212155 promotes tubular injury in ischemia\u2212induced acute kidney injury","volume":"50","author":"Zhang","year":"2022","journal-title":"Int J Mol Med"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.3390\/cells11091510","article-title":"Antigen cross-presentation by murine proximal tubular epithelial cells induces cytotoxic and inflammatory CD8(+) T cells","volume":"11","author":"Linke","year":"2022","journal-title":"Cells"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.148.8.2324","article-title":"Processing and presentation of self and foreign antigens by the renal proximal tubule","volume":"148","author":"Hagerty","year":"1992","journal-title":"J Immunol"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)66661-8","article-title":"Major histocompatibility complex class I and class II expression in renal cell carcinoma and modulation by interferon gamma","volume":"155","author":"Gastl","year":"1996","journal-title":"J Urol"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1084\/jem.157.6.2097","article-title":"Ia antigens in rat kidney, with special reference to their expression in tubular epithelium","volume":"157","author":"Mayrhofer","year":"1983","journal-title":"J Exp Med"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1990.46","article-title":"MHC class II, antigen presentation and tumor necrosis factor in renal tubular epithelial cells","volume":"37","author":"Wuthrich","year":"1990","journal-title":"Kidney Int"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1007\/BF00364353","article-title":"Graft-vs-host reactions induce H-2 class II gene transcription in host kidney cells","volume":"20","author":"Sinclair","year":"1984","journal-title":"Immunogenetics"},{"key":"B177","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4049\/jimmunol.134.1.7","article-title":"Induction of IA antigens in murine renal transplants","volume":"134","author":"Benson","year":"1985","journal-title":"J Immunol"},{"key":"B178","doi-asserted-by":"publisher","first-page":"F77","DOI":"10.1152\/ajprenal.00427.2018","article-title":"Renal proximal tubular epithelial cells exert immunomodulatory function by driving inflammatory CD4(+) T cell responses","volume":"317","author":"Breda","year":"2019","journal-title":"Am J Physiol Renal Physiol"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1159\/000064084","article-title":"B7-1 (CD80) and B7-2 (CD 86) expression in human tubular epithelial cells in vivo and in vitro","volume":"92","author":"Niemann-Masanek","year":"2002","journal-title":"Nephron"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00477.x","article-title":"Clinical significance of costimulatory molecules CD80\/CD86 expression in IgA nephropathy","volume":"65","author":"Wu","year":"2004","journal-title":"Kidney Int"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2005.01.005","article-title":"PD-L1 is expressed by human renal tubular epithelial cells and suppresses T cell cytokine synthesis","volume":"115","author":"Ding","year":"2005","journal-title":"Clin Immunol"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1084\/jem.180.4.1295","article-title":"The role of B cells in lpr\/lpr-induced autoimmunity","volume":"180","author":"Shlomchik","year":"1994","journal-title":"J Exp Med"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1992.242","article-title":"Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites","volume":"41","author":"Vlahakos","year":"1992","journal-title":"Kidney Int"},{"key":"B184","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nri2572","article-title":"Cracking the BAFF code","volume":"9","author":"Mackay","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"B185","doi-asserted-by":"publisher","first-page":"102980","DOI":"10.1016\/j.autrev.2021.102980","article-title":"Interplay of immune and kidney resident cells in the formation of tertiary lymphoid structures in lupus nephritis","volume":"20","author":"Jamaly","year":"2021","journal-title":"Autoimmun Rev"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1084\/jem.190.11.1697","article-title":"Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations","volume":"190","author":"Mackay","year":"1999","journal-title":"J Exp Med"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1385\/IR:27:2-3:141","article-title":"Peripheral B cell selection and homeostasis","volume":"27","author":"Cancro","year":"2003","journal-title":"Immunol Res"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1177\/0961203317717083","article-title":"Renal tubular epithelial cell-derived BAFF expression mediates kidney damage and correlates with activity of proliferative lupus nephritis in mouse and men","volume":"27","author":"Schwarting","year":"2018","journal-title":"Lupus"},{"key":"B189","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.clim.2016.08.010","article-title":"Cell death in the pathogenesis of systemic lupus erythematosus and lupus nephritis","volume":"185","author":"Mistry","year":"2017","journal-title":"Clin Immunol"},{"key":"B190","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1146\/annurev.iy.12.040194.004313","article-title":"The CD40 antigen and its ligand","volume":"12","author":"Banchereau","year":"1994","journal-title":"Annu Rev Immunol"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-7915(97)80078-7","article-title":"Functions of CD40 on B cells, dendritic cells and other cells","volume":"9","author":"Van Kooten","year":"1997","journal-title":"Curr Opin Immunol"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.160.5.2158","article-title":"Anti-CD40 ligand antibody treatment of SNF1 mice with established nephritis: preservation of kidney function","volume":"160","author":"Kalled","year":"1998","journal-title":"J\u00a0Immunol"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1006\/smim.1998.0145","article-title":"CD40 and its crucial role as a member of the TNFR family","volume":"10","author":"Vogel","year":"1998","journal-title":"Semin Immunol"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfu046","article-title":"Interaction between systemic inflammation and renal tubular epithelial cells","volume":"29","author":"Cantaluppi","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-023-01935-x","article-title":"Blockade of notch1 signaling alleviated podocyte injury in lupus nephritis via inhibition of NLRP3 inflammasome activation","volume":"47","author":"Wu","year":"2024","journal-title":"Inflammation"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddg211","article-title":"Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron","volume":"12","author":"Osaka","year":"2003","journal-title":"Hum Mol Genet"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-017-0512-x","article-title":"UCH-L1 expressed by podocytes: a potentially therapeutic target for lupus nephritis","volume":"40","author":"Cui","year":"2017","journal-title":"Inflammation"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.28282","article-title":"A20 overexpression exerts protective effects on podocyte injury in lupus nephritis by downregulating UCH-L1","volume":"234","author":"Sun","year":"2019","journal-title":"J Cell Physiol"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-019-00612-5","article-title":"SOCS1 and its potential clinical role in tumor","volume":"25","author":"Ying","year":"2019","journal-title":"Pathol Oncol Res"},{"key":"B200","doi-asserted-by":"publisher","first-page":"140810","DOI":"10.1016\/j.ijbiomac.2025.140810","article-title":"Molecular mechanism and role of miRNA-155 ribonucleic acid in podocyte apoptosis in lupus nephritis: SOCS1 protein expression regulates JAK\/STAT pathway transduction","volume":"304","author":"Pang","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.1018848","article-title":"Interaction between autophagy and the NLRP3 inflammasome in Alzheimer\u2019s and Parkinson\u2019s disease","volume":"14","author":"Lu","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.793924","article-title":"Salt-sensitivity of blood pressure and insulin resistance","volume":"12","author":"Ertuglu","year":"2021","journal-title":"Front Physiol"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S418598","article-title":"Identification of shared immune cells and immune-related co-disease genes in chronic heart failure and systemic lupus erythematosus based on transcriptome sequencing","volume":"16","author":"Luo","year":"2023","journal-title":"J Inflammation Res"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00049","article-title":"Mangiferin ameliorates hyperuricemic nephropathy which is associated with downregulation of AQP2 and increased urinary uric acid excretion","volume":"11","author":"Li","year":"2020","journal-title":"Front Pharmacol"},{"key":"B205","doi-asserted-by":"publisher","first-page":"111875","DOI":"10.1016\/j.intimp.2024.111875","article-title":"Fibroblast growth factor\u00a021\u00a0mitigates lupus nephritis progression via the FGF21\/Irgm 1\/NLRP3 inflammasome pathway","volume":"131","author":"Zou","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224242","article-title":"SGLT2 inhibitors alleviated podocyte damage in lupus nephritis by decreasing inflammation and enhancing autophagy","volume":"82","author":"Zhao","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2022-222512","article-title":"SGLT2 inhibitors in lupus nephropathy, a new therapeutic strategy for nephroprotection","volume":"81","author":"Morales","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222212476","article-title":"The role of NLRP3 inflammasome in lupus nephritis","volume":"22","author":"Oliveira","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B209","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1093\/ndt\/gfq496","article-title":"The PI3K\/Akt\/mTOR pathway is activated in murine lupus nephritis and downregulated by rapamycin","volume":"26","author":"Stylianou","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"B210","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0272-6386(12)80312-X","article-title":"Tubulointerstitial changes as a major determinant in the progression of renal damage","volume":"20","author":"Nath","year":"1992","journal-title":"Am J Kidney Dis"},{"key":"B211","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13075-015-0588-3","article-title":"Local synthesis of interferon-alpha in lupus nephritis is associated with type I interferons signature and LMP7 induction in renal tubular epithelial cells","volume":"17","author":"Castellano","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"B213","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/nyas.12756","article-title":"mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and aging","volume":"1346","author":"Perl","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1042\/CS20190536","article-title":"Effect of mycophenolate and rapamycin on renal fibrosis in lupus nephritis","volume":"133","author":"Zhang","year":"2019","journal-title":"Clin Sci (Lond)"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1177\/0961203307088289","article-title":"Rapamycin prevents\u00a0the development of nephritis in lupus-prone NZB\/W F1 mice","volume":"17","author":"Lui","year":"2008","journal-title":"Lupus"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.180507","article-title":"Longterm data on sirolimus treatment in patients with lupus nephritis","volume":"45","author":"Yap","year":"2018","journal-title":"J Rheumatol"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.08.075","article-title":"Vitamin D3 metabolite calcidiol primes human dendritic cells to promote the development of immunomodulatory IL-10-producing T cells","volume":"32","author":"Bakdash","year":"2014","journal-title":"Vaccine"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.3390\/nu7095383","article-title":"Regulation of dendritic cell function by vitamin D","volume":"7","author":"Barragan","year":"2015","journal-title":"Nutrients"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1177\/0961203319826704","article-title":"Expression of vitamin D receptor in renal tissue of lupus nephritis and its association with renal injury activity","volume":"28","author":"Sun","year":"2019","journal-title":"Lupus"},{"key":"B220","doi-asserted-by":"publisher","first-page":"108131","DOI":"10.1016\/j.intimp.2021.108131","article-title":"Role of vitamin D\/VDR nuclear translocation in down-regulation of NF-\u03baB\/NLRP3\/caspase-1 axis in lupus\u00a0nephritis","volume":"100","author":"Huang","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2018.10.025","article-title":"Piperine ameliorated lupus nephritis by targeting AMPK-mediated activation of NLRP3 inflammasome","volume":"65","author":"Peng","year":"2018","journal-title":"Int\u00a0Immunopharmacol"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.960601","article-title":"Fisetin reduces the senescent tubular epithelial cell burden and also inhibits proliferative fibroblasts in murine lupus nephritis","volume":"13","author":"Ijima","year":"2022","journal-title":"Front Immunol"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevOncog.2017025134","article-title":"Complex interplay between aging and cancer: role of TGF-\u03b2 Signaling","volume":"22","author":"Papageorgis","year":"2017","journal-title":"Crit Rev Oncog"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.18632\/aging.101202","article-title":"New agents that target senescent cells: the flavone, fisetin, and the BCL-X(L) inhibitors, A1331852 and A1155463","volume":"9","author":"Zhu","year":"2017","journal-title":"Aging (Albany NY)"},{"key":"B225","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ebiom.2018.09.015","article-title":"Fisetin is a senotherapeutic that extends health and lifespan","volume":"36","author":"Yousefzadeh","year":"2018","journal-title":"EBioMedicine"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2017.04.013","article-title":"Cellular senescence: A translational perspective","volume":"21","author":"Kirkland","year":"2017","journal-title":"EBioMedicine"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13141","article-title":"Senolytic drugs: from discovery to translation","volume":"288","author":"Kirkland","year":"2020","journal-title":"J Intern Med"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1126\/science.abe4832","article-title":"Senolytics reduce coronavirus-related mortality in old mice","volume":"373","author":"Camell","year":"2021","journal-title":"Science"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.09.012","article-title":"The lupus nephritis management renaissance","volume":"101","author":"Mejia-Vilet","year":"2022","journal-title":"Kidney Int"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-023-00597-3","article-title":"Lupus nephritis: new and emerging biologic and targeted therapies","volume":"37","author":"Kale","year":"2023","journal-title":"BioDrugs"},{"key":"B231","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10068-017-0008-3","article-title":"Comparison of structural features and antioxidant activity of polysaccharides from natural and cultured Cordyceps sinensis","volume":"26","author":"Wang","year":"2017","journal-title":"Food Sci Biotechnol"},{"key":"B232","doi-asserted-by":"publisher","first-page":"112566","DOI":"10.1016\/j.intimp.2024.112566","article-title":"Cordyceps protein alleviates renal injury by inhibiting T cell infiltration and Th1 cell differentiation in lupus nephritis mice","volume":"138","author":"Liao","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2018.0016","article-title":"Interleukin-2 deficiency associated with renal impairment in systemic lupus erythematosus","volume":"39","author":"Shao","year":"2019","journal-title":"J Interferon Cytokine Res"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215396","article-title":"Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial","volume":"79","author":"He","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B235","doi-asserted-by":"publisher","first-page":"103134","DOI":"10.1016\/j.autrev.2022.103134","article-title":"New insights for regulatory T cell in lupus nephritis","volume":"21","author":"Li","year":"2022","journal-title":"Autoimmun Rev"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.1177\/0961203315583541","article-title":"Combined transplantation of autologous hematopoietic stem cells and allogenic mesenchymal stem cells increases T regulatory cells in systemic lupus erythematosus with refractory lupus nephritis and leukopenia","volume":"24","author":"Wang","year":"2015","journal-title":"Lupus"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab877","article-title":"Long-term follow-up after lymphodepleting autologous haematopoietic cell transplantation for treatment-resistant systemic lupus erythematosus","volume":"61","author":"Goklemez","year":"2022","journal-title":"Rheumatol (Oxford)"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2015.89","article-title":"The regulation of the Treg\/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus","volume":"14","author":"Wang","year":"2017","journal-title":"Cell Mol Immunol"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.11340922","article-title":"The role of anti-B cell activating factor therapy for treating lupus nephritis","volume":"17","author":"Wooden","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"B240","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2023.09.002","article-title":"Clinical practice guideline for the management of LUPUS NEPHRITIS","volume":"105","year":"2024","journal-title":"Kidney Int"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1177\/0961203315588971","article-title":"Association of the interleukin-6 polymorphisms with systemic lupus erythematosus: a meta-analysis","volume":"24","author":"Cui","year":"2015","journal-title":"Lupus"},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201310","article-title":"Impact of anti-interleukin-6 receptor blockade on circulating T and B cell subsets in patients with systemic lupus erythematosus","volume":"72","author":"Shirota","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"B243","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"Clinical practice guideline for the management of glomerular diseases","volume":"100","year":"2021","journal-title":"Kidney Int"},{"key":"B244","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2016.12.011","article-title":"A comprehensive evaluation for the treatment of lupus nephritis","volume":"78","author":"Zampeli","year":"2017","journal-title":"J Autoimmun"},{"key":"B245","doi-asserted-by":"publisher","DOI":"10.1002\/art.10764","article-title":"The relationship of FcgammaRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus","volume":"48","author":"Anolik","year":"2003","journal-title":"Arthritis Rheum"},{"key":"B246","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-06-225979","article-title":"Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell-mediated B-cell cytotoxicity","volume":"115","author":"M\u00f6ssner","year":"2010","journal-title":"Blood"},{"key":"B247","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-07-588376","article-title":"Antigenic modulation limits the effector cell mechanisms employed by type I anti-CD20 monoclonal antibodies","volume":"125","author":"Tipton","year":"2015","journal-title":"Blood"},{"key":"B248","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/bjh.15232","article-title":"A tale of two antibodies: obinutuzumab versus rituximab","volume":"182","author":"Freeman","year":"2018","journal-title":"Br J Haematol"},{"key":"B249","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-220920","article-title":"B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial","volume":"81","author":"Furie","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"B250","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20102606","article-title":"Immunoglobulin binding protein 1 as a potential urine biomarker in patients with lupus nephritis","volume":"20","author":"Lee","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B251","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.09430915","article-title":"B cells, antibodies, and more","volume":"11","author":"Hoffman","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"B252","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-019-0129-z","article-title":"PI3K isoforms in cell signalling and vesicle trafficking","volume":"20","author":"Bilanges","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B253","doi-asserted-by":"publisher","DOI":"10.1172\/JCI176402","article-title":"PIK3CA inhibition in models of proliferative glomerulonephritis and lupus nephritis","volume":"134","author":"Yamaguchi","year":"2024","journal-title":"J\u00a0Clin Invest"},{"key":"B254","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.smim.2009.05.012","article-title":"CD40 and autoimmunity: the dark side of a great activator","volume":"21","author":"Peters","year":"2009","journal-title":"Semin Immunol"},{"key":"B255","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/PL00000776","article-title":"The CD40\/CD154 receptor\/ligand dyad","volume":"58","author":"Sch\u00f6nbeck","year":"2001","journal-title":"Cell Mol Life Sci"},{"key":"B256","doi-asserted-by":"publisher","DOI":"10.1172\/JCI147334","article-title":"The CD6\/ALCAM pathway promotes lupus nephritis via T cell-mediated responses","volume":"132","author":"Chalmers","year":"2022","journal-title":"J Clin Invest"},{"key":"B257","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25168981","article-title":"Lupus nephritis from pathogenesis to new therapies: an update","volume":"25","author":"Roveta","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B258","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00578-X","article-title":"Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial","volume":"397","author":"Rovin","year":"2021","journal-title":"Lancet"},{"key":"B259","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/art.42657","article-title":"Safety and efficacy of long-term voclosporin treatment for lupus nephritis in the phase 3 AURORA 2 clinical trial","volume":"76","author":"Saxena","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"B260","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.2005.00080.x","article-title":"Assessing the relative risk of cardiovascular disease among renal transplant patients receiving tacrolimus or cyclosporine","volume":"18","author":"Jardine","year":"2005","journal-title":"Transpl Int"},{"key":"B261","doi-asserted-by":"publisher","first-page":"481","DOI":"10.2215\/CJN.04800908","article-title":"Calcineurin inhibitor nephrotoxicity","volume":"4","author":"Naesens","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"B262","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1053\/j.ackd.2019.08.006","article-title":"The many faces of calcineurin inhibitor toxicity-what the FK","volume":"27","author":"Farouk","year":"2020","journal-title":"Adv Chronic Kidney Dis"},{"key":"B263","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a035436","article-title":"Identifying new substrates and functions for an old enzyme: calcineurin","volume":"12","author":"Roy","year":"2020","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B264","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.kint.2024.10.018","article-title":"Lupus nephritis: redefining the treatment goals","volume":"107","author":"De Vriese","year":"2025","journal-title":"Kidney Int"},{"key":"B265","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-023-00925-5","article-title":"Treatment of lupus nephritis: consensus, evidence and perspectives","volume":"19","author":"Mok","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"B266","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.05780616","article-title":"Update on lupus nephritis","volume":"12","author":"Almaani","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"B267","doi-asserted-by":"publisher","DOI":"10.1177\/0961203309358187","article-title":"Review: Lupus nephritis: pathologic features, epidemiology and a guide to therapeutic decisions","volume":"19","author":"Ortega","year":"2010","journal-title":"Lupus"},{"key":"B268","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2019.10.017","article-title":"Update on lupus nephritis: core curriculum 2020","volume":"76","author":"Parikh","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"B269","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016040415","article-title":"Current and emerging therapies for lupus nephritis","volume":"27","author":"Parikh","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B270","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfad055","article-title":"Diagnosis and treatment of lupus nephritis: a summary of the Consensus Document of the Spanish Group for the Study of Glomerular Diseases (GLOSEN)","volume":"16","author":"Rojas-Rivera","year":"2023","journal-title":"Clin Kidney J"},{"key":"B271","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01280122","article-title":"Short- and long-term progression of kidney involvement in systemic lupus erythematosus patients with low-grade proteinuria","volume":"17","author":"Wang","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"B272","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117643","article-title":"De novo synthesis and secretion of a 36-kD protein by cells that form lupus inclusions in response to alpha-interferon","volume":"95","author":"Rich","year":"1995","journal-title":"J Clin Invest"},{"key":"B273","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.11.023","article-title":"Revision of the International Society of Nephrology\/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices","volume":"93","author":"Bajema","year":"2018","journal-title":"Kidney Int"},{"key":"B274","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa381","article-title":"Lupus nephritis: clinical presentations and outcomes in the 21st century","volume":"59","author":"Gasparotto","year":"2020","journal-title":"Rheumatol (Oxford)"},{"key":"B275","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00443.x","article-title":"The classification of glomerulonephritis in systemic lupus erythematosus revisited","volume":"65","author":"Weening","year":"2004","journal-title":"Kidney Int"},{"key":"B276","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200608000-00015","article-title":"Interobserver reproducibility and application of the ISN\/RPS classification of lupus nephritis-a UK-wide study","volume":"30","author":"Furness","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"B277","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.smim.2006.12.004","article-title":"TLR signaling","volume":"19","author":"Kawai","year":"2007","journal-title":"Semin Immunol"},{"key":"B278","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00975","article-title":"Identification of renal long non-coding RNA RP11-2B6.2 as a positive regulator of type I interferon signaling pathway in lupus nephritis","volume":"10","author":"Liao","year":"2019","journal-title":"Front Immunol"},{"key":"B279","doi-asserted-by":"publisher","DOI":"10.1038\/nri910","article-title":"NF-kappaB regulation in the immune system","volume":"2","author":"Li","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"B280","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct Target Ther"},{"key":"B281","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12967-016-0911-z","article-title":"Anti-dsDNA antibodies bind to TLR4 and activate NLRP3 inflammasome in lupus monocytes\/macrophages","volume":"14","author":"Zhang","year":"2016","journal-title":"J Transl Med"},{"key":"B282","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-016-8550-y","article-title":"The role of STAT signaling pathways in the pathogenesis of systemic lupus erythematosus","volume":"52","author":"Goropev\u0161ek","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"B283","doi-asserted-by":"publisher","first-page":"395","DOI":"10.22074\/cellj.2015.1","article-title":"STATs: an old story, yet mesmerizing","volume":"17","author":"Abroun","year":"2015","journal-title":"Cell J"},{"key":"B284","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-016-0250-0","article-title":"Role of Notch signaling in regulating innate immunity and inflammation in health and disease","volume":"7","author":"Shang","year":"2016","journal-title":"Protein Cell"},{"key":"B285","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41392-022-00934-y","article-title":"Notch signaling pathway: architecture, disease, and therapeutics","volume":"7","author":"Zhou","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"B286","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00627.x","article-title":"The role of Notch signaling in specification of podocyte and proximal tubules within the developing mouse kidney","volume":"68","author":"Cheng","year":"2005","journal-title":"Kidney Int"},{"key":"B287","doi-asserted-by":"publisher","DOI":"10.1242\/dev.02733","article-title":"Mapping the consequence of Notch1 proteolysis in vivo with NIP-CRE","volume":"134","author":"Vooijs","year":"2007","journal-title":"Development"},{"key":"B288","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007050596","article-title":"Ectopic notch activation in developing podocytes causes glomerulosclerosis","volume":"19","author":"Waters","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"B289","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41467-017-00498-4","article-title":"Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling","volume":"8","author":"Liu","year":"2017","journal-title":"Nat Commun"},{"key":"B290","doi-asserted-by":"publisher","DOI":"10.1080\/08820139.2022.2027440","article-title":"MicroRNA-30a targets notch1 to alleviate podocyte injury in lupus nephritis","volume":"51","author":"Guo","year":"2022","journal-title":"Immunol Invest"},{"key":"B291","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00837.x","article-title":"Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies","volume":"66","author":"Li","year":"2004","journal-title":"Kidney Int"},{"key":"B292","doi-asserted-by":"publisher","DOI":"10.3390\/ijms14046863","article-title":"Impact of notch signaling on inflammatory responses in cardiovascular disorders","volume":"14","author":"Quillard","year":"2013","journal-title":"Int J Mol Sci"},{"key":"B293","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/s41392-024-02018-5","article-title":"Renal remodeling by CXCL10-CXCR3 axis-recruited mesenchymal stem cells and subsequent IL4I1 secretion in lupus nephritis","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B294","doi-asserted-by":"publisher","first-page":"6194864","DOI":"10.1155\/2020\/6194864","article-title":"Role of chemokine (C-X-C motif) ligand 10 (CXCL10) in renal diseases","volume":"2020","author":"Gao","year":"2020","journal-title":"Mediators Inflammation"},{"key":"B295","doi-asserted-by":"publisher","DOI":"10.1186\/ar2541","article-title":"Mapping similarities in mTOR pathway perturbations in mouse lupus nephritis models and human lupus nephritis","volume":"10","author":"Reddy","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"B296","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200838618","article-title":"B-cell responses to B-cell activation factor of the TNF family (BAFF) are impaired in the absence of PI3K delta","volume":"38","author":"Henley","year":"2008","journal-title":"Eur J Immunol"},{"key":"B297","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1471-2172-10-28","article-title":"A kinase-dead knock-in mutation in mTOR leads to early embryonic lethality and is dispensable for the immune system in heterozygous mice","volume":"10","author":"Shor","year":"2009","journal-title":"BMC Immunol"},{"key":"B298","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2004.03.014","article-title":"Phosphoinositide 3-kinase and its targets in B-cell and T-cell signaling","volume":"16","author":"Fruman","year":"2004","journal-title":"Curr Opin Immunol"},{"key":"B299","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.621300","article-title":"Role of NLRP3 inflammasome in lupus nephritis and therapeutic targeting by phytochemicals","volume":"12","author":"Wu","year":"2021","journal-title":"Front Pharmacol"},{"key":"B300","doi-asserted-by":"publisher","first-page":"20221038","DOI":"10.1515\/biol-2022-1038","article-title":"Sirt1 protects lupus nephritis by inhibiting the NLRP3 signaling pathway in human glomerular mesangial cells","volume":"20","author":"Zhao","year":"2025","journal-title":"Open Life Sci"},{"key":"B301","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12950-018-0192-9","article-title":"Expression and clinical significance of the NEK7-NLRP3 inflammasome signaling pathway in patients with systemic lupus erythematosus","volume":"15","author":"Ma","year":"2018","journal-title":"J Inflammation (Lond)"},{"key":"B302","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/1471-2164-11-365","article-title":"Transcriptional regulation of gene expression clusters in motor neurons following spinal cord injury","volume":"11","author":"Ryge","year":"2010","journal-title":"BMC Genomics"},{"key":"B303","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1228704","article-title":"Signaling to NF-kappaB","volume":"18","author":"Hayden","year":"2004","journal-title":"Genes Dev"},{"key":"B304","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/1465-9921-10-100","article-title":"TGF-beta1 induced epithelial to mesenchymal transition (EMT) in human bronchial epithelial cells is enhanced by IL-1beta but not abrogated by corticosteroids","volume":"10","author":"Doerner","year":"2009","journal-title":"Respir Res"},{"key":"B305","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.114.24.4359","article-title":"Smad regulation in TGF-beta signal transduction","volume":"114","author":"Moustakas","year":"2001","journal-title":"J Cell Sci"},{"key":"B306","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(05)80001-7","article-title":"Distinct roles for the costimulatory ligands B7\u20131 and B7\u20132 in T helper cell differentiation","volume":"81","author":"Thompson","year":"1995","journal-title":"Cell"},{"key":"B307","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830261027","article-title":"CD28-deficient mice generate an impaired Th2 response to Schistosoma mansoni infection","volume":"26","author":"King","year":"1996","journal-title":"Eur J Immunol"},{"key":"B308","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.9.3245","article-title":"Dendritic cells: unique leukocyte populations which control the primary immune response","volume":"90","author":"Hart","year":"1997","journal-title":"Blood"},{"key":"B309","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-1030","article-title":"The B7 family and cancer therapy: costimulation and coinhibition","volume":"13","author":"Zang","year":"2007","journal-title":"Clin Cancer Res"},{"key":"B310","doi-asserted-by":"publisher","DOI":"10.2174\/1568010053586228","article-title":"Therapeutic blockade of TCR signal transduction and co-stimulation in autoimmune disease","volume":"4","author":"Howard","year":"2005","journal-title":"Curr Drug Targets Inflammation Allergy"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1682075\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T05:11:52Z","timestamp":1764047512000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1682075\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":310,"alternative-id":["10.3389\/fimmu.2025.1682075"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1682075","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"article-number":"1682075"}}